This Year's Flu Shot - Only 10% Effective?

The Male Birth Control Pill

By Alexa Lardieri , Staff Writer, US News A CONTRACEPTIVE PILL for men is a step closer to approval after early trials of a once-daily pill showed it to be safe and effective, according to researchers. The new pill, known as DMAU for its chemical name, dimethandrolone undecanoate, is similar to the female birth control pill. It contains a combination of hormones – an androgen, like testosterone, and progestin – said the study's senior investigator, Dr. Stephanie Page, a professor of medicine at the University of Washington. Taken daily, it could bring sperm count low enough so a man cannot get his partner pregnant. "DMAU is a major step forward in the development of a once-daily 'male pill,'" Page said at the Endocrine Society's annual conference. "Many men say they would prefer a daily pill as a reversible contraceptive, rather than long-acting injections or topical gels, which are also in development." Developmen

Stop Taking That Aspirin You Were Told To Take

Taking a low-dose aspirin every day to prevent a heart attack or stroke is no longer recommended for most older adults, according to guidelines released Sunday. After doctors said for decades that a daily 75 to 100 milligrams of aspirin could prevent cardiovascular problems, the American College of Cardiology and the American Heart Association reversed that idea. A large clinical trial found a daily low-dose aspirin had no effect on prolonging life in healthy, elderly people and actually suggested the pills could be linked to major hemorrhages. Sunday's recommendations say low-dose aspirin should not be given to prevent atherosclerotic cardiovascular disease on a routine basis to adults older than 70 or any adult at an increased risk of bleeding. “Clinicians should be very selective in prescribing aspirin for people without known cardiovascular disease,” cardiologist Roger Blumenthal said in a statement . "It’s much more important to optimize lifestyle habi

CPRTrainingFast

Search This Blog